ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $65,960 | -45.9% | 17,000 | -66.0% | 0.01% | -53.8% |
Q3 2022 | $122,000 | -22.8% | 50,000 | -37.5% | 0.01% | 0.0% |
Q2 2022 | $158,000 | -42.5% | 80,000 | -46.7% | 0.01% | -56.7% |
Q1 2022 | $275,000 | +29.7% | 150,000 | 0.0% | 0.03% | +30.4% |
Q4 2021 | $212,000 | -9.0% | 150,000 | -27.2% | 0.02% | -20.7% |
Q3 2021 | $233,000 | -11.1% | 206,000 | +25.6% | 0.03% | -12.1% |
Q2 2021 | $262,000 | +48.9% | 164,000 | +64.0% | 0.03% | +26.9% |
Q1 2021 | $176,000 | -9.7% | 100,000 | 0.0% | 0.03% | -16.1% |
Q4 2020 | $195,000 | +36.4% | 100,000 | +66.7% | 0.03% | -11.4% |
Q3 2020 | $143,000 | +146.6% | 60,000 | +200.0% | 0.04% | +84.2% |
Q2 2020 | $58,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |